Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Matrix_Laboratories
Merck KGaA's generics business |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:dissolved |
2020
|
| gptkbp:foundedBy |
gptkb:Milan_Puskar
gptkb:Don_Panoz |
| gptkbp:foundedYear |
1961
|
| gptkbp:headquartersLocation |
gptkb:Canonsburg,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mylan
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Heather_Bresch
gptkb:Robert_J._Coury |
| gptkbp:mergedInto |
gptkb:Upjohn
|
| gptkbp:notableProduct |
gptkb:EpiPen
|
| gptkbp:numberOfEmployees |
35000
|
| gptkbp:products |
generic drugs
specialty pharmaceuticals |
| gptkbp:successor |
gptkb:Viatris
|
| gptkbp:tradedOn |
gptkb:NASDAQ:_MYL
|
| gptkbp:website |
www.mylan.com
|
| gptkbp:bfsParent |
gptkb:Heather_Manchin_Bresch
|
| gptkbp:bfsLayer |
6
|